Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

Jean‐Louis Chiasson(Centre Hospitalier de l’Université de Montréal), Robert G. Josse(St. Michael's Hospital), Ramón Gomis(Hospital Universitari de Vic), M Hanefeld, Avraham Karasik(Sheba Medical Center), Markku Laakso(University of Eastern Finland)
The Lancet
June 1, 2002
Cited by 2,545

Abstract


Related Papers

No related papers found

Powered by citation graph analysis